Boston Atrial Fibrillation Symposium

Home Faculty Program Registration Information Policy On Disclosure Local Attractions

THE FTP UPLOAD SITE IS CLOSED. PLEASE BRING YOUR FINAL PRESENTATIONS ON A THUMB DRIVE TO THE SPEAKER READY ROOM ONSITE AT THE SEAPORT/WTC. THANK YOU.

Program

THURSDAY JANUARY 14, 2010 REGISTRATION: 8:00 AM - 12:00 Noon Exhibit Floor 11:00 AM - 5:00 PM All Lectures are followed by a 5-minute question and answer session.
THURSDAY JANUARY 14, 2010 Afternoon Scientific Session 1:00 PM-6:00 PM
1:00 - 1:10 PM	Introduction and Overview of the Symposium Jeremy Ruskin, MD
1:15 - 1:35 PM	The History of Atrial Fibrillation: A Century of Progress Eric Prystowsky, MD
1:40 - 2:00 PM	New Observations on Mechanisms Underlying the Transition from Organization to Fractionation of Atrial Electrical Activity During AF Jose Jalife, MD
2:05 - 2:25 PM	Basic Mechanisms by Which Exercise Training Promotes AF Stanley Nattel, MD
2:30 - 2:50 PM	Atrial Fibrillation in Competitive Athletes - Prevalence, Pathophysiology and Management Riccardo Cappato, MD
2:55 - 3:15 PM	Determinants of Atrial Thrombosis in Experimental AF - Arrhythmia vs. Substrate Stanley Nattel, MD
3:20 - 3:50 PM	Coffee Break and Exhibits
3:50 - 4:10 PM	Role of Inflammation in the Pathogenesis of AF Shih-Ann Chen, MD
4:15 - 4:35 PM	Management of Asymptomatic AF in Young, Middle-Aged and Elderly Patients A. John Camm, MD
4:40 - 5:00 PM	Update on Indications, Results and Future Directions of Surgery for AF Ralph Damiano, Jr., MD
5:05 - 6:00 PM	Difficult Cases in AF Management (Antiarrhythmic Drugs, Anticoagulation, and Clinical Decision Making) Panel and Audience Discussion Moderator: Jeremy Ruskin, MD Panel: A. John Camm, MD, Riccardo Cappato, MD, Peter Kowey, MD, Eric Prystowsky, MD and Albert Waldo, MD
6:00 PM	Adjourn
FRIDAY JANUARY 15, 2010 Morning Scientific Session 7:00 AM - 12:10 PM
6:00 - 7:00 AM	Continental Breakfast
7:00 - 10:00 AM	Satellite Case Transmissions: Catheter Ablation for Atrial Fibrillation Moderator: Jeremy Ruskin, MD Panel: Pierre Jais, MD, Shih-Ann Chen, MD, Francis Marchlinski, MD, and David Wilber, MD Massachusetts General Hospital, Boston, Massachusetts Moussa Mansour, MD, Kevin Heist, MD, PhD and Conor Barrett, MD Mayo Clinic, Rochester, Minnesota Douglas Packer, MD and Samuel Asirvatham, MD
10:00 - 10:30 AM	Coffee Break and Exhibits
10:30 - 10:50 AM	Emerging Role of Transcription Factors in the Development of AF: Insights from Genetic Studies Patrick Ellinor, MD, PhD
10:55 - 11:15 AM	Epidemiology and Predicting Risk for Atrial Fibrillation Emelia Benjamin, MD
11:20 - 11:40 AM	Classification of Symptoms in AF - Rationale, Methods and Limitations Jeremy Ruskin, MD
11:45 - 12:05 PM	The Promise and Peril of New Antiarrhythmic Drug Development: What Is the New Path Forward After ATHENA? Peter Kowey, MD
12:10 - 1:00 PM	Lunch and Exhibits
FRIDAY JANUARY 15, 2010 Afternoon Scientific Session 1:00 PM - 6:10 PM
1:00 - 2:55 PM	MiniSymposium on Stroke Prevention in Atrial Fibrillation: A New Era of Drugs and Devices Moderator: Daniel Singer, MD Overview of Long-term Anticoagulation for AF - Where We Stand in 2010 (20 min) Daniel Singer, MD Completed Phase III Trials of Dabigatran and Other Agents RE-LY, ACTIVE A, W & I) - Design, Results and Clinical Implications (20 min) Stuart Connolly, MD The Significance of Atrial Arrhythmias Detected by Implanted Devices (15 min) Albert Waldo, MD Left Atrial Appendage Exclusion Devices: Current Clinical Trials (20 min) Zoltan Turi, MD Panel and Audience Discussion: (40 min) What Will Be the Role for Dabigatran and Other Novel Agents vs. Warfarin Going Forward? Will LAA Occlusion/Exclusion Replace Long-Term Anticoagulation to Prevent Stroke in AF? Moderator: Hasan Garan, MD Panel: Stuart Connolly, MD, Vivek Reddy, MD, Daniel Singer, MD, Zoltan Turi, MD, and Albert Waldo, MD
2:55 - 3:25 PM	Coffee Break and Exhibits
3:25 - 4:05 PM	Regulatory Issues in AF Ablation Moderator: Hugh Calkins, MD FDA Perspective on AF Ablation Studies - A New Regulatory Landscape (10 min) Randall Brockman, MD Sponsor vs. Single-Site Investigator Initiated Clinical Studies to Support a Market Application for AF Devices (10 min) Jun Dong, MD Audience Question and Answer Session (20 min)
4:05 - 4:25 PM	Current Status of Clinical Trials of AF Ablation Devices Seeking FDA Approval Hugh Calkins, MD
4:30 - 4:50 PM	New Observations from the Second Worldwide Survey on AF Ablation Riccardo Cappato, MD
4:55 - 5:15 PM	Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation Carlo Pappone, MD, PhD
5:20 - 5:40 PM	Progression of Atrial Fibrillation: Impact on Ablation Strategies and Outcomes David Wilber, MD
5:45 - 6:05 PM	Monitoring after AF Ablation: Implications for Long-term Anticoagulation Hans Kottkamp, MD
6:10 PM	Adjourn
SATURDAY JANUARY 16, 2010 Morning Scientific Session 7:30 AM - 12:30 PM
6:30 - 7:30 AM	Continental Breakfast
7:30 - 8:30 AM	Panel: Practical Approaches to Catheter Ablation (all talks 15 min) Moderator: Douglas Packer, MD BOX Isolation for AF - Rationale, Technique and Outcomes - Koichiro Kumagai, MD Mitral Isthmus Ablation - A New Approach - Karl-Heinz Kuck, MD Difficult Transseptals & SVC Isolation - Vivek Reddy, MD Coronary Sinus and Persistent Left SVC Isolation - David Keane, MD, PhD
8:35 - 8:55 AM	The Use of Multielectrode Catheters for Electroanatomic Mapping During Catheter Ablation of Atrial Fibrillation Moussa Mansour, MD
9:00 - 9:20 AM	4 and 5-D Image-Integrated Mapping for Atrial Fibrillation Ablation Douglas Packer, MD
9:25 - 9:45 AM	Endpoints for Catheter Ablation of AF Revisited Francis Marchlinski, MD
9:50 - 10:20 AM	Coffee Break and Exhibits
10:20 - 11:00 AM	Debate: Termination of AF is a Useful Procedural Endpoint and Predictor of Outcome for Catheter Ablation of Persistent AF (all talks 20 min) Moderator: Hans Kottkamp, MD Pro: Pierre Jais, MD Con: Andrea Natale, MD
11:05 - 12:05 PM	MiniSymposium on Contact Force Sensing (all talks 15 min) Moderator: David Keane, MD, PhD Clinical Feasibility Study of Contact Force Sensing - Karl-Heinz Kuck, MD Control of RF Lesion Size Using a New Contact Force Sensor - Hiroshi Nakagawa, MD, PhD Observations on a New Capacitance Force Sensor - Gerhard Hindricks, MD Force-Time Integral and Perforating Force Threshold: New Parameters for Improving the Efficacy and Safety of Catheter Ablation - Dipen Shah, MD
12:10 - 12:30 AM	Atrial Flutter After AF Ablation - Incidence, Predictors, Mechanisms and Management Pierre Jais, MD
12:35 - 1:20 PM	Lunch and Exhibits
SATURDAY JANUARY 16, 2010 Afternoon Scientific Session 1:20 PM - 5:45 PM
1:20 - 2:00 PM	Debate: Entrainment Mapping is Preferable to 3-D Activation Sequence Mapping for Ablation of Left Atrial Tachycardias After PVI (all talks 20 min) Moderator: Frank Marchlinski, MD Pro: Gerhard Hindricks, MD Con: Hiroshi Nakagawa, MD, PhD
2:10 - 2:30 PM	Interaction of Central and Intrinsic Cardiac Autonomic Nervous System in AF Warren Jackman, MD
2:35 - 3:35 PM	Optimizing the Safety of Catheter Ablation for AF (all talks 10 min) Moderator: David Wilber, MD Pulmonary Vein Stenosis - Douglas Packer, MD Esophageal Injury - Conor Barrett, MD Safety of Uninterrupted Warfarin Use in AF Ablation - Andrea Natale, MD Other Short and Long Term Complications of AF Ablation - Andre d'Avila, MD, PhD Panel and Audience Discussion (20 min) Panel: Andre d'Avila, MD, PhD, Conor Barrett, MD, Koichiro Kumagai, MD, Andrea Natale, MD, Douglas Packer, MD and Carlo Pappone, MD, PhD
3:40 - 4:00 PM	Balloon-Based Systems for AF Ablation - Outcomes and Complications Vivek Reddy, MD
4:05 - 4:25 PM	Current Status of Remote and Robotic Navigation for AF Ablation Andrea Natale, MD
4:30 - 4:45 PM	Ice Cream Break
4:45 - 5:45 PM	Interesting and Challenging Cases in AF Management Panel and Audience Discussion Moderator: Vivek Reddy, MD Panel: Pierre Jais, MD Karl Heinz-Kuck, MD, Moussa Mansour, MD, Francis Marchlinski, MD and David Wilber, MD
5:45 PM	Adjourn

	Designed and Developed by:
	SilverSwitch Consulting, Inc.